These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33853174)

  • 1. [When to test in biomarker-stratified therapy of non-small cell lung cancer - Biomarker-stratified therapy of Non-small cell lung cancer: when and what to test?].
    Griesinger F; Thomas M
    Dtsch Med Wochenschr; 2021 Apr; 146(8):559-561. PubMed ID: 33853174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [When to Test in Biomarker-stratified Therapy of Non-small Cell Lung Cancer - Biomarker-stratified Therapy of Non-small Cell Lung Cancer: When and What to Test?].
    Griesinger F; Thomas M
    Pneumologie; 2021 Sep; 75(9):641-643. PubMed ID: 34525486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
    Felip E; Concha Á; de Castro J; Gómez-Román J; Garrido P; Ramírez J; Isla D; Sanz J; Paz-Ares L; López-Ríos F
    Clin Transl Oncol; 2015 Feb; 17(2):103-12. PubMed ID: 25351175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).
    Garrido P; de Castro J; Concha Á; Felip E; Isla D; López-Ríos F; Paz-Ares L; Ramírez J; Sanz J; Gómez JJ
    Clin Transl Oncol; 2012 May; 14(5):338-49. PubMed ID: 22551539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancer.
    Ellis PM; Blais N; Soulieres D; Ionescu DN; Kashyap M; Liu G; Melosky B; Reiman T; Romeo P; Shepherd FA; Tsao MS; Leighl NB
    J Thorac Oncol; 2011 Aug; 6(8):1379-91. PubMed ID: 21709590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker testing in non-small cell lung cancer: to move forward with quality.
    Stahel R
    Clin Transl Oncol; 2012 May; 14(5):321-2. PubMed ID: 22551535
    [No Abstract]   [Full Text] [Related]  

  • 7. Defining comprehensive biomarker-related testing and treatment practices for advanced non-small-cell lung cancer: Results of a survey of U.S. oncologists.
    Mileham KF; Schenkel C; Bruinooge SS; Freeman-Daily J; Basu Roy U; Moore A; Smith RA; Garrett-Mayer E; Rosenthal L; Garon EB; Johnson BE; Osarogiagbon RU; Jalal S; Virani S; Weber Redman M; Silvestri GA
    Cancer Med; 2022 Jan; 11(2):530-538. PubMed ID: 34921524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society--abridged version].
    Goeckenjan G; Sitter H; Thomas M; Branscheid D; Flentje M; Griesinger F; Niederle N; Stuschke M; Blum T; Deppermann KM; Ficker JH; Freitag L; Lübbe AS; Reinhold T; Späth-Schwalbe E; Ukena D; Wickert M; Wolf M; Andreas S; Auberger T; Baum RP; Baysal B; Beuth J; Bickeböller H; Böcking A; Bohle RM; Brüske I; Burghuber O; Dickgreber N; Diederich S; Dienemann H; Eberhardt W; Eggeling S; Fink T; Fischer B; Franke M; Friedel G; Gauler T; Gütz S; Hautmann H; Hellmann A; Hellwig D; Herth F; Heussel CP; Hilbe W; Hoffmeyer F; Horneber M; Huber RM; Hübner J; Kauczor HU; Kirchbacher K; Kirsten D; Kraus T; Lang SM; Martens U; Mohn-Staudner A; Müller KM; Müller-Nordhorn J; Nowak D; Ochmann U; Passlick B; Petersen I; Pirker R; Pokrajac B; Reck M; Riha S; Rübe C; Schmittel A; Schönfeld N; Schütte W; Serke M; Stamatis G; Steingräber M; Steins M; Stoelben E; Swoboda L; Teschler H; Tessen HW; Weber M; Werner A; Wichmann HE; Irlinger Wimmer E; Witt C; Worth H; ;
    Pneumologie; 2011 Aug; 65(8):e51-75. PubMed ID: 21830177
    [No Abstract]   [Full Text] [Related]  

  • 9. Updates Regarding Biomarker Testing for Non-Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable.
    Kim ES; Roy UB; Ersek JL; King J; Smith RA; Martin N; Martins R; Moore A; Silvestri GA; Jett J
    J Thorac Oncol; 2019 Mar; 14(3):338-342. PubMed ID: 30709747
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chinese expert consensus on the multidisciplinary clinical diagnosis and treatment of stage Ⅲ non-small cell lung cancer (2019)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):881-890. PubMed ID: 31874543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summary of presentations from the 46th Annual Meeting of the American Society of Clinical Oncology: focus on non-small cell lung cancer (2010).
    Stinchcombe TE; Baggstrom MQ; Somaiah N; Simon GR; Govindan R
    J Thorac Oncol; 2011 Jan; 6(1):227-32. PubMed ID: 21178721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation.
    Gosney JR; Paz-Ares L; Jänne P; Kerr KM; Leighl NB; Lozano MD; Malapelle U; Mok T; Sheffield BS; Tufman A; Wistuba II; Peters S
    ESMO Open; 2023 Aug; 8(4):101587. PubMed ID: 37356358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarker Testing for Patients With Advanced Non-Small Cell Lung Cancer: Real-World Issues and Tough Choices.
    Pennell NA; Arcila ME; Gandara DR; West H
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():531-542. PubMed ID: 31099633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-small cell lung cancer. New biomarkers for diagnostics and therapy].
    Kayser G
    Pathologe; 2015 Nov; 36 Suppl 2():189-93. PubMed ID: 26391246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-small cell lung cancer.
    Ettinger DS; Akerley W; Borghaei H; Chang AC; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Ganti AK; Govindan R; Grannis FW; Horn L; Jahan TM; Jahanzeb M; Kessinger A; Komaki R; Kong FM; Kris MG; Krug LM; Lennes IT; Loo BW; Martins R; O'Malley J; Osarogiagbon RU; Otterson GA; Patel JD; Pinder-Schenck MC; Pisters KM; Reckamp K; Riely GJ; Rohren E; Swanson SJ; Wood DE; Yang SC; Hughes M; Gregory KM;
    J Natl Compr Canc Netw; 2012 Oct; 10(10):1236-71. PubMed ID: 23054877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best-practice guide.
    Fox AH; Nishino M; Osarogiagbon RU; Rivera MP; Rosenthal LS; Smith RA; Farjah F; Sholl LM; Silvestri GA; Johnson BE
    CA Cancer J Clin; 2023; 73(4):358-375. PubMed ID: 36859638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive summary of the SEPAR recommendations for the diagnosis and treatment of non-small cell lung cancer.
    Villar Álvarez F; Muguruza Trueba I; Belda Sanchis J; Molins López-Rodó L; Rodríguez Suárez PM; Sánchez de Cos Escuín J; Barreiro E; Borrego Pintado MH; Disdier Vicente C; Flandes Aldeyturriaga J; Gámez García P; Garrido López P; León Atance P; Izquierdo Elena JM; Novoa Valentín NM; Rivas de Andrés JJ; Royo Crespo Í; Salvatierra Velázquez Á; Seijo Maceiras LM; Solano Reina S; Aguiar Bujanda D; Avila Martínez RJ; de Granda Orive JI; de Higes Martinez E; Diaz-Hellín Gude V; Embún Flor R; Freixinet Gilart JL; García Jiménez MD; Hermoso Alarza F; Hernández Sarmiento S; Honguero Martínez AF; Jimenez Ruiz CA; López Sanz I; Mariscal de Alba A; Martínez Vallina P; Menal Muñoz P; Mezquita Pérez L; Olmedo García ME; Rombolá CA; San Miguel Arregui I; de Valle Somiedo Gutiérrez M; Triviño Ramírez AI; Trujillo Reyes JC; Vallejo C; Vaquero Lozano P; Varela Simó G; Zulueta JJ
    Arch Bronconeumol; 2016 Jul; 52(7):378-88. PubMed ID: 27237592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid biomarker testing for improved clinical decision-making in nonsmall cell lung cancer.
    Kaplan EH
    MLO Med Lab Obs; 2017 Jun; 49(6):12-4, 16-8. PubMed ID: 29952196
    [No Abstract]   [Full Text] [Related]  

  • 19. Do we have markers to select patients for adjuvant therapies of non-small-cell lung cancer?
    Konopa K
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii199-202. PubMed ID: 20943615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus conference on palliative treatment of stage IV non-small cell lung cancer. Consensus meeting of the Netherlands Society for Medical Oncology and the Taskforce on Lung Cancer of the Dutch Society of Physicians for Lung Diseases and Tuberculosis.
    Tjan-Heijnen VC; Groen HJ; Schramel FM; Stoter G;
    Neth J Med; 2001 Feb; 58(2):52-61. PubMed ID: 11166446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.